コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 anges, including activation of genes such as atrial natriuretic factor.
2 tricular output, and possibly high levels of atrial natriuretic factor.
3 icular expression of the load-sensitive gene atrial natriuretic factor.
4 They also express the gene for atrial natriuretic factor.
5 e an 8-fold increase in ventricular mRNA for atrial natriuretic factor.
6 osin heavy chain, myosin light chain 2v, and atrial natriuretic factor.
7 nduction of fetal genes such as betaMyHC and atrial natriuretic factor.
8 d expression of the hypertrophic marker gene atrial natriuretic factor.
9 lmonary congestion and had reduced levels of atrial natriuretic factor.
10 ricles expressed beta-myosin heavy chain and atrial natriuretic factor.
11 y reduced ET-1- and PE-induced expression of atrial natriuretic factor.
12 e, sarcomeric organization, and induction of atrial natriuretic factor.
14 ed in the morphants including an increase in atrial natriuretic factor, a hallmark for cardiac hypert
15 we find that fluorescence from Topaz-tagged atrial natriuretic factor, a peptidergic vesicle pH indi
16 LV fibrosis, and expression of fetal genes (atrial natriuretic factor, alpha-skeletal muscle actin,
17 spholamban restored the expression levels of atrial natriuretic factor and alpha-skeletal actin mRNA
18 function and decreased cardiac expression of atrial natriuretic factor and alpha-skeletal actin mRNA.
19 n neonatal hearts, ventricular expression of atrial natriuretic factor and alpha-skeletal actin was m
20 ore, mRNA expressions of the embryonic genes atrial natriuretic factor and alpha-skeletal actin were
21 arkers of hypertrophy, alpha-skeletal actin, atrial natriuretic factor and beta-MyHC, were upregulate
23 ificantly increased heart/body weight ratio, atrial natriuretic factor and beta-myosin heavy chain mR
24 hearts demonstrate significant induction of atrial natriuretic factor and beta-myosin heavy chain tr
25 e cross-sectional areas, hypertrophy markers atrial natriuretic factor and beta-myosin heavy chain).
26 ition, two cardiac hypertrophy marker genes, atrial natriuretic factor and beta-myosin heavy chain, w
27 en synthesis and hypertrophy markers such as atrial natriuretic factor and beta-myosin heavy chain.
28 enuated expression of the trabecular markers atrial natriuretic factor and bone morphogenic protein 1
29 el pathways associated with up-regulation of atrial natriuretic factor and brain natriuretic peptide
30 ist-induced expression of the embryonic gene atrial natriuretic factor and enlargement of cardiomyocy
31 f the expression of various genes, including atrial natriuretic factor and Ifi204 (encoding p204).
32 d and endothelin-1-mediated induction of the atrial natriuretic factor and myosin light chain-2 genes
34 activated reporter expression from both the atrial natriuretic factor and myosin light chain-2 ventr
35 trophy, increased expression of fetal genes (atrial natriuretic factor and skeletal alpha-actin), dec
37 cardiac expression of HF marker genes (GRK2, atrial natriuretic factor, and beta-myosin heavy chain).
38 yosin heavy chain, cardiac troponin I and T, atrial natriuretic factor, and cardiac transcription fac
39 ncrease in cell size, elevated expression of atrial natriuretic factor, and induction of sarcomere or
40 RNA expression of brain natriuretic peptide, atrial natriuretic factor, and renin were significantly
42 i.e. those for c-Fos, skeletal alpha-actin, atrial natriuretic factor, and the alpha3-subunit of Na+
43 19%), secreted more apoB, and expressed less atrial natriuretic factor (ANF) and brain natriuretic pe
44 5 haploinsufficiency also markedly decreased atrial natriuretic factor (ANF) and connexin 40 (cx40) t
45 function, its synergism with partners at the atrial natriuretic factor (ANF) and connexin-40 (Cx40) p
46 are markers of cardiac hypertrophy including atrial natriuretic factor (ANF) and myosin light chain-2
47 (GSK3beta) is critical for transcription of atrial natriuretic factor (ANF) by beta-adrenergic recep
49 induced increases in NADPH oxidase activity, atrial natriuretic factor (ANF) expression, and cardiac
50 promoter/luciferase reporter genes, increase atrial natriuretic factor (ANF) expression, and promote
51 terized by transcriptional activation of the atrial natriuretic factor (ANF) gene and enlargement (hy
54 otic expression screen for activators of the atrial natriuretic factor (ANF) gene, a cardiac-specific
56 its DNA binding sites in the promoter of the atrial natriuretic factor (ANF) gene, an in vivo target
57 immediate early genes, and up-regulates the atrial natriuretic factor (ANF) gene, but does not affec
58 h considerable evidence indicates a role for atrial natriuretic factor (ANF) in renal salt regulation
61 In contrast, while MnTMPyP inhibited basal atrial natriuretic factor (ANF) mRNA expression, the str
64 containing c-Jun and with the cardiomyocyte atrial natriuretic factor (anf) promoter and the cardiac
66 can induce reporter gene expression from the atrial natriuretic factor (ANF) promoter, a genetic mark
71 bx20, activates a cardiac-specific promoter (atrial natriuretic factor (ANF)) alone and synergistical
72 messenger ribonucleic acid (mRNA) levels of atrial natriuretic factor (ANF), beta-myosin heavy chain
74 embryonic hearts expressed similar levels of atrial natriuretic factor (ANF), brain natriuretic pepti
75 cular expression of several genes, including atrial natriuretic factor (ANF), has been documented in
77 perated with c-Raf to increase expression of atrial natriuretic factor (ANF), whereas N17Rac1 inhibit
78 tivator of p38, stimulated the expression of atrial natriuretic factor (ANF), which is a genetic mark
83 ve mRNA levels of the hypertrophy-associated atrial natriuretic factor (ANF, 2.1-fold) and skeletal a
84 nduced expression of two hypertrophic genes (atrial natriuretic factor [ANF] and c-myc) and also enha
85 al hydrolysis of ligand (125I-labeled native atrial natriuretic factor, ANF1-28), and receptor recycl
86 pregulation of hypertrophy markers including atrial natriuretic factor, beta-MHC, and GATA4; and acti
87 onic and contractile protein genes including atrial natriuretic factor, beta-myosin heavy chain, and
88 expression of the hypertrophic marker genes, atrial natriuretic factor, brain natriuretic peptide, an
90 We investigated the potential of a C-type atrial natriuretic factor (C-ANF) to image developing pl
91 of mRNAs for fetal type myosin heavy chain, atrial natriuretic factor, c-fos, transforming growth fa
92 ently, we reported the (64)Cu-labeled C-type atrial natriuretic factor (CANF) fragment for detecting
93 pressed genes including cardiac alpha actin, atrial natriuretic factor, cardiac myosin heavy chain al
94 o well-known markers of cardiac hypertrophy (atrial natriuretic factor, CARP, and beta-myosin heavy c
95 , overexpression of NF-kappaB itself induced atrial natriuretic factor expression and cardiomyocyte e
96 heart-to-body weight ratios with ventricular atrial natriuretic factor expression denoting myocardial
97 ment, sarcomeric organization, and increased atrial natriuretic factor expression in association with
98 P79 attenuated cardiomyocyte hypertrophy and atrial natriuretic factor expression in response to angi
101 ng Ras-induced myofibrillar organization and atrial natriuretic factor expression was only minimally
102 ha(1B)AR-induced hypertrophy and ventricular atrial natriuretic factor expression were significantly
103 ction, which induced myocyte hypertrophy and atrial natriuretic factor expression, protected against
109 MAPK cascade, and (c) induction of c-fos or atrial natriuretic factor gene occurred partly through t
110 ocardin A transactivated the promoter of the atrial natriuretic factor gene through the serum respons
111 ssion of cardiac-specific promoters from the atrial natriuretic factor gene, the b-type natriuretic p
114 ytosis were developed by expressing a prepro-atrial natriuretic factor-green fluorescent protein fusi
115 ganization, increased cell size, and induced atrial natriuretic factor in cardiomyocytes plated on th
116 els of cardiac hypertrophy and expression of atrial natriuretic factor in Mekk1(-/-) animals, which s
117 s-sectional area, and hypertrophy-associated atrial natriuretic factor induction following pressure o
118 days) did not affect the trophic response or atrial natriuretic factor induction to pressure overload
119 c mass, myocyte size, hypertrophy-associated atrial natriuretic factor induction, and c-Jun N-termina
120 The C3 treatment inhibited Ang II-induced atrial natriuretic factor induction, whereas it had no e
121 r studies of singular prevention strategies (atrial natriuretic factor, loop diuretics, dopamine, man
122 iferase gene expression but no activation of atrial natriuretic factor-luciferase gene expression.
123 accumulation, coincident with activation of atrial natriuretic factor-luciferase gene expression.
124 O mice shows a dramatic up-regulation of the atrial natriuretic factor message, a well-established bi
125 ET-1 also induced a significant increase in atrial natriuretic factor mRNA expression as well as in
126 here were no significant changes in IGF-1 or atrial natriuretic factor mRNA levels in response to GH
127 There was also an increase in ventricular atrial natriuretic factor mRNA levels, demonstrating act
129 n reaction, we measured transcript levels of atrial natriuretic factor, myosin heavy chain-alpha and
131 mg/mm; p<0.001) and reduced LV expression of atrial natriuretic factor (p<0.05), alpha-skeletal muscl
132 hy like: alpha- and beta-myosin heavy chain, atrial natriuretic factor, phospholamban, and sarcoplasm
133 in cell size, sarcomeric reorganization, and atrial natriuretic factor production were remarkably att
134 ponse when assessed by protein synthesis and atrial natriuretic factor production, a marker gene of h
137 as co-transfected with SRF, but it repressed atrial natriuretic factor promoter activity, which was s
138 P-TF2dependent synergistic activation of the atrial natriuretic factor promoter by both GATA4 and the
139 educed the capability of SRF to activate the atrial natriuretic factor promoter that contains the ser
145 and of the other retinal guanylate cyclase, atrial natriuretic factor-receptor guanylate cyclase.
146 onomous accumulation of the endocytic tracer atrial natriuretic factor-red fluorescent protein at ear
147 that TBX5 activates the transcription of an atrial natriuretic factor reporter construct and this ef
148 ons of the genes of skeletal alpha-actin and atrial natriuretic factor, repression of the gene of the
151 However, in vivo imaging of a neuropeptide, atrial natriuretic factor, tagged with green fluorescent
156 cific markers desmin, sarcomeric myosin, and atrial natriuretic factor was similar to that of culture
158 ing adult heart, steady-state mRNA levels of atrial natriuretic factor were increased in both the fet
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。